Efinaconazole

艾氟康唑

Report date: 2022/04/20 15:23:04
NME

Base Information

Drug NameEfinaconazole
Drug Alias Name依非康唑efinaconazolumefinaconazol艾菲康唑艾非康唑 +[10] 
ClassificationSmall molecules > Heterocyclic drugs > Antifungals
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsOnychomycosis
Global Approved IndicationsOnychomycosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved Date2013/10/02
Country/TerritoryCanadaUnited StatesMexico +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesKaken Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBausch & Lomb (Singapore) Pvi LtdKaken Pharmaceutical Co Ltd
Inactive CompaniesWestern University Of Health SciencesDow Pharmaceutical Sciences Inc
Active IndicationsOnychomycosis
Inactive IndicationsN/A

Other Information

ATC CodeD01AC19
Related LinksWikipediaDrugBankKEGG